<![CDATA[Cantargia AB: Cantargia reports positive results in ongoing]]>
Link Preview Image
Cantargia reports positive results in ongoing phase IIa clinical trial in pancreatic cancer using nadunolimab and chemotherapy | Cantargia

favicon

(cantargia.com)

]]>https://dev.proinvestor.com/forum/topic/442690/cantargia-ab-cantargia-reports-positive-results-in-ongoingRSS for NodeTue, 07 Jul 2026 00:49:43 GMTThu, 20 May 2021 02:11:23 GMT60<![CDATA[Reply to Cantargia AB: Cantargia reports positive results in ongoing on Fri, 21 May 2021 05:47:18 GMT]]>Ligner en færdig aktie...20% ned på 2 dage

]]>https://dev.proinvestor.com/forum/post/9467036https://dev.proinvestor.com/forum/post/9467036Fri, 21 May 2021 05:47:18 GMT<![CDATA[Reply to Cantargia AB: Cantargia reports positive results in ongoing on Thu, 20 May 2021 09:33:43 GMT]]>Utroligt kursen ikke stiger mere, men god mulighed for at supplere lidt op... Redeye bedömer att nya data från CANFOUR-studien i bukspottkörtelcancer kring överlevnad och längd på behandlingssvar är tydligt lovande.
Cantargia redovisar data kring behandlingseffekt avseende progressionsfri överlevnad (PFS) och total överlevnad från patienter med bukspottkörtelcancer som har behandlats med CAN04 plus cellgiftsbehandlingen gemcitabin/nab-paclitaxel i fas IIa-studien CANFOUR.

]]>https://dev.proinvestor.com/forum/post/9467037https://dev.proinvestor.com/forum/post/9467037Thu, 20 May 2021 09:33:43 GMT<![CDATA[Reply to Cantargia AB: Cantargia reports positive results in ongoing on Thu, 20 May 2021 06:48:55 GMT]]>Cantargia, Capital Markets Day, 2021

May 20th 2021 15:00 (Europe/Stockholm)
Language:
English
Speaker:
CEO, Göran Forsberg. VP Research, David Liberg. CMO, Ignacio Garcia-Ribas. Ahmad Awada, Professor at Institut Jules Bordet and Manuel Hidalgo Medina, M.D. Ph.D. Chief of the Division of Hematology and Medical Oncology at Weill Cornell Medicine.
Sector:
Health care - Pharmaceuticals & Biotechnology
Listing:
Mid Cap
Activity:
Capital Markets Day

Tilmelding:

Link Preview Image
Cantargia, Capital Markets Day, 2021 | Financial Hearings by Inderes

favicon

(financialhearings.com)

]]>https://dev.proinvestor.com/forum/post/9467041https://dev.proinvestor.com/forum/post/9467041Thu, 20 May 2021 06:48:55 GMT<![CDATA[Reply to Cantargia AB: Cantargia reports positive results in ongoing on Thu, 20 May 2021 06:21:25 GMT]]>MSE 66.058 209.627 -143.569
MLEX 100.224 231.079 -130.855

]]>https://dev.proinvestor.com/forum/post/9467038https://dev.proinvestor.com/forum/post/9467038Thu, 20 May 2021 06:21:25 GMT<![CDATA[Reply to Cantargia AB: Cantargia reports positive results in ongoing on Thu, 20 May 2021 06:20:45 GMT]]>Lad os håbe det, og at "banditterne" snart
stopper deres udsalg

]]>https://dev.proinvestor.com/forum/post/9467035https://dev.proinvestor.com/forum/post/9467035Thu, 20 May 2021 06:20:45 GMT<![CDATA[Reply to Cantargia AB: Cantargia reports positive results in ongoing on Thu, 20 May 2021 06:06:14 GMT]]>Vi må håbe at præsentationen senere i dag kan flytte kursen betydligt op. Jeg kan at Redeye mener at kursen burde stige med 15-20% på baggrund af dagens meddelelse.

]]>https://dev.proinvestor.com/forum/post/9467032https://dev.proinvestor.com/forum/post/9467032Thu, 20 May 2021 06:06:14 GMT<![CDATA[Reply to Cantargia AB: Cantargia reports positive results in ongoing on Thu, 20 May 2021 05:45:56 GMT]]>Merrill Lynch og Morgan Stanley fortsætter desværre udsalget....uanset hvilke nyheder der kommer.

]]>https://dev.proinvestor.com/forum/post/9467039https://dev.proinvestor.com/forum/post/9467039Thu, 20 May 2021 05:45:56 GMT